Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wockhardt spurts on reporting Q4 PAT at Rs 164 cr
Wockhardt surged 8.03% to Rs 1,540 after the company reported a sharp turnaround in quarterly earnings, aided by strong growth in key geographies.
Wockhardt jumps 10% on posting Q4 profit turnaround; revenue up 30% YoY
In the March quarter (Q4FY26), Wockhardt posted net profit year-on-year (Y-o-Y) of ₹166 crore, as compared to a net loss of ₹25 crore a year ago
Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth
Wockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performance. Net profit turned positive, and revenue saw a substantial increase. Full-year earnings also showed improvement. Biotech operations were a key growth driver, with expansion in emerging markets. The company also expanded its product pipeline with new filings and approvals.
Stock Alert: Wockhardt, Jindal Stainless, Petronet LNG, Manappuram Finance, Aarti Industries
Larsen & Toubro, Mahindra and Mahindra, Punjab National Bank, Marico, Hero Motocorp, Lloyds Metals and Energy, SRF, Coforge, United Breweries, Poonawalla Fincorp, Ajanta Pharma, Emcure Pharmaceuticals, Aadhar Housing Finance, Gallantt Ispat, Jammu and Kashmir Bank, Voltamp Transformers, AAVAS Financiers, Lloyds Engineering Works, Alkyl Amines Chemicals, SJS Enterprises, Shilchar Technologies, GNG Electronics, Gujarat Heavy Chemicals, Aeroflex Industries, Shanthi Gears, Shoppers Stop, Dalmia Bharat Sugar and Industries, Cigniti Technologies, Raymond Realty, Raymond, Shipping Corporation of India Land and Assets, PTC India Financial Services, Spandana Sphoorty Financial, Dolphin Offshore Enterprises (India), CFF Fluid Control, DCW, Automobile Corporation of Goa (ACGL), Paushak, Mafatlal Industries, B Right Realestate, Kothari Petrochem, Foseco Crucible (India), Sutlej Textiles and Industries, Primo Chemicals, Onward Technologies, Kriti Nutrients, Jenburkt Pharma, Kriti Industries ..
Wockhardt reports consolidated net profit of Rs 166.00 crore in the March 2026 quarter
Sales rise 29.88% to Rs 965.00 crore
Wockhardt shares rise as company swings to ₹164 crore Q4 profit; revenue up 30%
Wockhardt Ltd posts Q4 net profit of ₹164 crore vs loss last year, revenue up 30% to ₹965 crore, EBITDA and margins surge, shares close 2.54% higher.
Q4 Results LIVE Updates: DMart shares down 4%, ideaForge Technologies up 16%; Ambuja report today
Q4 Results LIVE Updates: Amubja Cements, Manappuram Finance, Godrej Properties, Aditya Birla Capital, Tata Technologies, KEI Industries, Jindal Stainless, BHEL, Aarti Industries, Sobha, Quess Corp, Tata Chemicals, Wockhardt, are among the companies reporting their earnings today. Also watch for earnings reactions from Avenue Supermarts, Kotak Mahindra Bank, CDSL, NSDL, Zen Technologies, Mazagon Dock and others. Watch this space for all the LIVE earnings reactions.
CEAT Ltd leads losers in 'A' group
K P R Mill Ltd, Craftsman Automation Ltd, Electrosteel Castings Ltd and Wockhardt Ltd are among the other losers in the BSE's 'A' group today, 13 March 2026.
Wockhardt snaps five-day rally, falls 7% on profit-booking despite upbeat Zaynich outlook
The decline came despite positive commentary from Chairman Habil F Khorakiwala on the company's novel antibiotic Zaynich
'The difficult part is behind us' — Habil Khorakiwala on the long road to Zaynich and Wockhardt’s reinvention
'Over the last 10–12 years, we had five or six meetings with the US FDA. We would explain exactly what we intended to do, and they would guide us — whether they agreed, disagreed or wanted changes... There were no shortcuts,' the Wockhardt founder-chairman tells Moneycontrol
Wockhardt opts for self-commercialisation of Zaynich over licensing to maximise value: Chairman
The decision marks a departure from the route often taken by Indian drugmakers
Buzzing Stocks: PNC Infra, IndiGo, Wockhardt rally; Inox Wind slips on weak Q4 results
Marksans Pharma shares edged down after the company signed a definitive agreement to acquire 100 percent of the share capital of QliniQ B.V.,.